Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
TMPRSS2-ERG gene rearrangement, the most common E26 transformation specific (ETS) gene fusion within prostate cancer, is known to contribute to the pathogenesis of this disease and carries diagnostic annotations for prostate cancer patients clinically.